Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy-Reference-Cited by-同舟云学术

Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy

Published:2019-02-08 Issue:7 Volume:53 Page:690-696
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Yamamoto Keisuke¹,Sasano Tomomi¹,Tsuji Daiki²,Ishizuka Yuichi¹,Tokou Umi¹,Nakamichi Hidenori¹,Yoneda Tatsuaki¹,Shiokawa Mitsuru³,Yabe Katsushige¹

Affiliation:

1. SEIREI Hamamatsu General Hospital, Naka-ku, Japan

2. University of Shizuoka, Japan

3. SEIREI Yokohama Hospital, Japan

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/1060028019830785

Reference24 articles.

1. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

2. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

3. Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

4. Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

5. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer;European Journal of Clinical Pharmacology;2023-01-16

2. Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2021-12

3. Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer;Investigational New Drugs;2021-11-18